Scientific evidence for a fixed extract combination (Ze 91019) from Valerian and hops traditionally used as a sleep-inducing aid

Wiener Medizinische Wochenschrift

Volumn 157, Issue 13-14, 2007, Pages 367-370

  Brattström, Axel ^a,b  

^a Max Zeller Sohne AG   (Switzerland)

^b Zeller Medical AG   (Switzerland)

Author keywords

Combination; Efficacy; Humulus lupulus; Sleep disorder; Valeriana officinalis

Indexed keywords

ADENOSINE; HUMULUS LUPULUS EXTRACT; MELATONIN; VALERIAN;

DRUG EFFICACY; DRUG TOLERABILITY; FRONTAL CORTEX; HUMAN; HUMULUS LUPULUS; MEDICINAL PLANT; NONHUMAN; PHYTOTHERAPY; REVIEW; SLEEP DISORDER; SLEEP INDUCTION; VALERIANA OFFICINALIS;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; HUMANS; HUMULUS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT PREPARATIONS; RATS; SLEEP DISORDERS; VALERIAN;

EID: 34548407052     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-007-0442-6     Document Type: Review

References (30)

1. Borbély AA, Achermann P (2000) Homeostasis of human sleep and models of sleep regulation. In: Kryger MH, Roth T, Dement WC (eds.) Principles and Practise of Sleep Medicine. WB Saunders, Philadelphia, pp. 377-390
2. Finelli LA, Baumann H, Borbély AA, Achermann P (2000) Dual electroencephalogram markers of human sleep homeostasis: correlation between theta activity in waking and slow wave activity in sleep; Neuroscience 101(3): 523-529
3. Cajochen C, Kräuchi K, Wirz-Justice (2003) Role of melatonin in the regulation of human circadian rhythms and sleep; J Neuroendocrinol 15: 432-437
4. Porkka-Heiskanen T, Alanko L, Kalinchuk A, Stenberg D (2002) Adenosine and sleep; Sleep Med Rev 6(4): 321-332
5. Müller CE, Schuhmacher B, Brattström A, Abourashed EA, Koetter U (2002) Interaction of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors. Life Sci 71: 1939-1949
6. Schuhmacher B, Scholle S, Hölzl J, Khudeir N, Hess S, Müller CE (2002) Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A1 adenosine receptor. J Nat Prod 65: 1479-1485
7. Lacher SK, Mayer R, Sichardt K, Nieber K, Müller CE (2007) Interaction of valerian extracts of different polarity with adenoside receptors: identification of isovaltrate as an inverse agonist at A1 receptors. Biochem Pharmacol 73(2):248-258
8. Vissiennon Z, Sichardt K, Koetter U, Brattström A, Nieber K (2006) Valerian extract Ze 911 inhibits postsynaptic potentials by activation of adenosine A1 receptors in rat cortical neurons. Planta Med 72: 579-583
9. Brattström A, Nieber K, Sichardt K, Vissiennon Z, Koetter U (2006) Valerian extract prepared with methanol but not with ethanol or ethyl acetate inhibits the postsynaptic potentials in rat cortical neurons indicating an adenosine-like action. Planta Med 72: 1048 (P223)
10. Dimpfel W, Brattström A, Koetter U (2006) Central action of a fixed valerian-hops extract combination (Ze 91019) in freely moving rats. Eur J Med Res 11: 496-500
11. Schellenberg R, Sauer S, Abourashed EA, Koetter U, Brattström A (2004) The fixed combination of valerian and hops (Ze 91019) acts via a central adenosine mechanism. Planta Med 70: 594-597
12. Santos MS, Ferreira F, Cunha AP, Carvalho AP, Ribeiro CF, Macedo T (1994) Synaptosomal GABA release as influenced by valerian rot extract-involvement o the GABA carrier. Arch Pharmacodyn Ther 327: 220-231
13. 3H]GABA release. Neurochem Res 24: 1373-1378
14. Wiener SW, Hoffman RS, Nelson LS (2003) Withdrawal symptoms after valerian cessation. J Toxicol Clin Toxicol 41: 721
15. Weels SR. (1995) Intentional intravenous administration of a crude valerian root extract. J Toxicol Clin Toxicol 33: 542
16. Khom S, Baburin I, Timin EN, Hohaus A, Sieghart W, Hering S (2006) Pharmacological properties of GABA receptor containing gammal subunits. Mol Pharmacol 69: 640-649
17. A-action on its receptors. Planta Med 72: 104
18. Trauner G, Khom S, Benedek B, Hering S, Kopp B (2006) Identification of GABAA-modulators obtained from Valeriana officinalis L. Planta Med 72: 998
19. Abourashed EA, Koetter U, Brattström A (2004) In vitro binding experiments with valerian, hops and their fixed combination extract (Ze 91019) to selected central nervous receptors. Phytomedicine 11:633-638
20. 5a receptor in vitro. Molecular Brain Res 138 (2): 191-197
21. 3H] MK-801 binding to rat synaptic membranes. Phytotherapy Res 20(9): 794-798
22. A receptors and their lateral mobility at hippocampal neurons. Planta Med 72: 656-658
23. Zanoli P, Zavatti M, Rivasi M, Brusinani, Losi G, Puia G, Avallone R, Baraldi M (2007) Evidence that the beta-acids fraction of hops reduces central GABAergic neurotransmission; J Ethnopharmacol 109 (1): 656-661
24. Lee KM, Jung JS, Song DK, Kräuter M, Kim YH (1993) Effects of Kumulus lupulus extract on the central nervous system in mice. Planta Med 59(Suppl): A 691
25. Schiller H, Forster A, Vonhoff C, Hegger M, Biller A, Winterhoff H (2006) Sedating effects of Kumulus lupulus L. extracts. Phytomedicine 13: 535-541
26. Zanoli P, Rivasi M, Zavatti M, Brusiani F, Baraldi M (2005) New insight in the neuropharmacological activity of Humulus lupulus L. J Ethnopharmacol 102: 102-106
27. Butterweck V, Brattstroem A, Grundmann O, Koetter U (2007) Hypothermic effects of hops are antagonized with the competitive melatonin receptor antagonist luzindole in mice. J Pharmacy Pharmacol 59: 549-552
28. Rodenbeck A, Simen S, Cohrs S, Jordan W, Kinkelbur J, Staedt J, Hajak G (1998) Veränderte Schlafstrukturen als Hinweis auf die GABAerge Wirkung eines Baldrian-Hopfen-Präparates bei Patienten mit psychophysiologischer Insomnie. Somnologie 2: 26-31
29. Füssel A, Wolf A, Brattström A (2000) Effect of a fixed valerian hop extract combination (Ze 91019) on sleep polygraphia in patients with non-organic insomnia: a pilot study. Eur J Med Res 5: 385-390
30. Koetter U, Schrader E, Brattström A (2006) Effects of hops on clinical efficacy of a valerian-hops-extract combination (Ze 91019) in patients suffering from non-organic sleep disorder. Planta Med 72: 977